BioMed Research International / 2016 / Article / Tab 5

Research Article

Association between the Achievement of Target Range CKD-MBD Markers and Mortality in Prevalent Hemodialysis Patients in Taiwan by Using the Kidney Disease: Improving Global Outcomes Clinical Guidelines

Table 5

Odds ratio of all-cause and CV mortality by achievement of KDIGO clinical guideline, iPTH target.

OR (95% CI)
Model 1Model 2Model 3

iPTH (pg/mL), all-cause
<1441.70 (1.25~2.33)<0.0012.00 (1.31~3.05)0.0011.95 (1.21~3.14)0.006
>6481.67 (1.03~2.70)0.032.14 (1.21~3.77)0.0081.47 (0.77~2.81)0.24

iPTH (pg/mL), CV
<1441.12 (0.60~2.12)0.721.20 (0.54~2.70)0.651.68 (0.70~4.02)0.24
>6480.69 (0.21~2.31)0.541.00 (0.28~3.54)0.990.54 (0.13~2.21)0.39

Logistic regression model:
Model 1: unadjusted.
Model 2: adjusted for age, sex, hemodialysis vintage, etiology of renal failure, EPO, vitamin-D analogs, antihypertensive agent, iron use, and parathyroidectomy.
Model 3: model 2 + baseline laboratory results (albumin, hemoglobin, cholesterol, triglyceride, glucose (fasting), ferritin, Ca, P, potassium, uric acid, urea, and cardiac-thoracic ratio).

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.